Prexton Therapeutics
Latest round
- Series B
Last raised
- Feb 2017
Total raised
- $43M
Investors
- 5
About Prexton Therapeutics
Founded in 2012 and based in Geneva, Switzerland, Prexton Therapeutics SA develops drugs for treatment of Parkinson’s disease and other central nervous system disorders.
Who invested in Prexton Therapeutics
5 investors across 3 rounds
See all investors in Prexton Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prexton Therapeutics
Who invested in Prexton Therapeutics?
Prexton Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prexton Therapeutics raised?
Prexton Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Prexton Therapeutics last raise money?
Prexton Therapeutics's most recent round on record is a Series B, in Feb 2017.
What does Prexton Therapeutics do?
Founded in 2012 and based in Geneva, Switzerland, Prexton Therapeutics SA develops drugs for treatment of Parkinson’s disease and other central nervous system disorders.
Where is Prexton Therapeutics headquartered?
Prexton Therapeutics is headquartered in Netherlands.
Which VCs invest in companies like Prexton Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Prexton Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Prexton Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.